HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model.

AbstractOBJECTIVES:
High-dose insulin (HDI) has inotropic and vasodilatory properties in various clinical conditions associated with myocardial depression. The authors hypothesized that HDI will improve the myocardial depression produced by severe septic shock and have beneficial effects on metabolic parameters. In an animal model of severe septic shock, this study compared the effects of HDI treatment to normal saline (NS) resuscitation alone.
METHODS:
Ten pigs were randomized to an insulin (HDI) or NS group. All were anesthetized and instrumented to monitor cardiovascular function. In both arms, Escherichia coli endotoxin lipopolysaccharide (LPS) and NS infusions were begun. LPS was titrated to 20 mug/kg/hour over 30 minutes and continued for 5 hours, and saline was infused at 20 mL/kg/hour throughout the protocol. Dextrose (50%) was infused to maintain glucose in the 60-150 mg/dL range, and potassium was infused to maintain a level greater than 2.8 mmol/L. At 60 minutes, the HDI group received an insulin infusion titrated from 2 to 10 units/kg/hour over 40 minutes and continued at that rate throughout the protocol. Survival, heart rate (HR), mean arterial pressure (MAP), pulmonary artery and central venous pressure, cardiac output, central venous oxygen saturation (SVO(2)), and lactate were monitored for 5 hours (three pigs each arm) or 7 hours (two pigs each arm) or until death. Cardiac index, systemic vascular resistance (SVR), pulmonary vascular resistance (PVR), O(2) delivery, and O(2) consumption were derived from measured data. Outcomes from the repeated-measures analysis were modeled using a mixed-effects linear model that assumed normally distributed errors and a random effect at the subject level.
RESULTS:
No significant baseline differences existed between arms at time 0 or 60 minutes. Survival was 100% in the HDI arm and 60% in the NS arm. Cardiovascular variables were significantly better in the HDI arm: cardiac index (p < 0.001), SVR (p < 0.003), and PVR (p < 0.01). The metabolic parameters were also significantly better in the HDI arm: SVO(2) (p < 0.01), O(2) delivery (p < 0.001), and O(2) consumption (p < 0.001). No differences in MAP, HR, or lactate were found.
CONCLUSIONS:
In this animal model of endotoxemic-induced septic shock that results in severe myocardial depression, HDI is associated with improved cardiac function compared to NS resuscitation alone. HDI also demonstrated favorable metabolic, pulmonary, and peripheral vascular effects. Further studies may define a potential role for the use of HDI in the resuscitation of septic shock.
AuthorsJoel S Holger, David J Dries, Kelly W Barringer, Benjamin J Peake, Thomas J Flottemesch, John J Marini
JournalAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine (Acad Emerg Med) Vol. 17 Issue 4 Pg. 429-35 (Apr 2010) ISSN: 1553-2712 [Electronic] United States
PMID20370783 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Insulin
  • Lactates
  • Oxygen
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Cardiac Output (drug effects)
  • Cardiovascular System (drug effects)
  • Confidence Intervals
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Heart Rate (drug effects)
  • Infusions, Intravenous
  • Insulin (pharmacology)
  • Lactates (metabolism)
  • Myocardial Contraction (drug effects)
  • Oxygen (blood)
  • Oxygen Consumption (physiology)
  • Probability
  • Random Allocation
  • Reference Values
  • Risk Factors
  • Shock, Septic (drug therapy, mortality, physiopathology)
  • Survival Rate
  • Swine
  • Vascular Resistance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: